Publication & news
Together, let’s uncover tomorrow’s secrets, today.
Together, let’s uncover tomorrow’s secrets, today.
Faecalibacterium prausnitzii Induces an Anti-inflammatory Response and a Metabolic Reprogramming in Human Monocytes
G. Bensimon
Gastroenterology - 2026
ISO 9001 Certification: QMS Certification Renewal 2026
January 21, 2026
Parean Biotechnologies
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): phase 2b, double-blind, randomised, placebo-controlled trial
G. Bensimon
The Lancet - 2025
Faecalibacterium prausnitzii induces an anti-inflammatory and a metabolic reprogramming in human monocytes
N. Rolhion, H Sokol
Journal of Crohn's and colitis - 2025
Develop New TCR-Based therapies and biomarkers
February 20, 2025
Immudex x Parean: Strategic Partnership dCODE
February 13, 2025
Antigen-specific T & B cells Characterization
Resident memory CD8+T cell subpopulations in patients with non-small-cell lung cancer
Paolini L, Tartour E
Journal for ImmunoTherapy of Cancer - 2024
CIR Agreement: Renewal 2024- 2026
November 27, 2024
Parean Biotechnologies
High-throughput identification of immunogenic B and T cell epitopes meets deep immune cell phenotyping
October 9, 2024